• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙贝病毒逃避 NKG2D 介导的细胞毒性免疫。

Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.

机构信息

Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA.

Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.

出版信息

Cell. 2024 May 9;187(10):2393-2410.e14. doi: 10.1016/j.cell.2024.03.026. Epub 2024 Apr 22.

DOI:10.1016/j.cell.2024.03.026
PMID:38653235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11088510/
Abstract

SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an activating receptor conserved among mammals that recognizes infection-induced stress ligands (e.g., MIC-A/B). We found that SARS-CoV-2 evades NKG2D recognition by surface downregulation of MIC-A/B via shedding, observed in human lung tissue and COVID-19 patient serum. Systematic testing of SARS-CoV-2 proteins revealed that ORF6, an accessory protein uniquely conserved among sarbecoviruses, was responsible for MIC-A/B downregulation via shedding. Further investigation demonstrated that natural killer (NK) cells efficiently killed SARS-CoV-2-infected cells and limited viral spread. However, inhibition of MIC-A/B shedding with a monoclonal antibody, 7C6, further enhanced NK-cell activity toward SARS-CoV-2-infected cells. Our findings unveil a strategy employed by SARS-CoV-2 to evade cytotoxic immunity, identify the culprit immunevasin shared among sarbecoviruses, and suggest a potential novel antiviral immunotherapy.

摘要

SARS-CoV-2 和其他沙贝科病毒继续威胁着人类,这凸显出需要对病毒免疫逃逸的常见机制进行特征分析,以为大流行的防范做好准备。细胞毒性淋巴细胞对抗病毒免疫至关重要,它们表达 NKG2D,这是一种在哺乳动物中保守的激活受体,可识别感染诱导的应激配体(例如 MIC-A/B)。我们发现,SARS-CoV-2 通过脱落来下调 MIC-A/B 的表面表达来逃避 NKG2D 的识别,这在人肺组织和 COVID-19 患者血清中都有观察到。对 SARS-CoV-2 蛋白的系统测试表明,ORF6 是一种在沙贝科病毒中独特保守的辅助蛋白,通过脱落来负责 MIC-A/B 的下调。进一步的研究表明,自然杀伤 (NK) 细胞可有效杀死 SARS-CoV-2 感染的细胞并限制病毒的传播。然而,用单克隆抗体 7C6 抑制 MIC-A/B 的脱落可进一步增强 NK 细胞对 SARS-CoV-2 感染细胞的活性。我们的发现揭示了 SARS-CoV-2 逃避细胞毒性免疫的一种策略,鉴定了沙贝科病毒之间共有的免疫逃逸因子,并提出了一种潜在的新型抗病毒免疫疗法。

相似文献

1
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.沙贝病毒逃避 NKG2D 介导的细胞毒性免疫。
Cell. 2024 May 9;187(10):2393-2410.e14. doi: 10.1016/j.cell.2024.03.026. Epub 2024 Apr 22.
2
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D.SARS-CoV-2 通过 Nsp1 介导的下调 NKG2D 的配体来逃避直接 NK 细胞杀伤。
Cell Rep. 2022 Dec 27;41(13):111892. doi: 10.1016/j.celrep.2022.111892. Epub 2022 Dec 12.
3
SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity.SARS-CoV-2 肽与 NKG2D 结合并增加 NK 细胞活性。
Cell Immunol. 2022 Jan;371:104454. doi: 10.1016/j.cellimm.2021.104454. Epub 2021 Nov 7.
4
Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion.前列腺肿瘤来源的外泌体下调自然杀伤细胞和CD8 + T细胞上NKG2D的表达:免疫逃逸机制
PLoS One. 2014 Sep 30;9(9):e108925. doi: 10.1371/journal.pone.0108925. eCollection 2014.
5
Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.可溶性 NKG2D 受体配体在 HIV-1 感染过程中释放,并损害 NK 细胞的 NKG2D 表达和细胞毒性。
FASEB J. 2013 Jun;27(6):2440-50. doi: 10.1096/fj.12-223057. Epub 2013 Feb 8.
6
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.表达于结肠腺癌的MHC I类链相关分子对自然杀伤细胞免疫的逃逸
J Immunol. 2003 Dec 15;171(12):6891-9. doi: 10.4049/jimmunol.171.12.6891.
7
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.免疫刺激的MHC I类链相关分子的普遍表达在前列腺癌中因脱落作用而受到抑制。
J Clin Invest. 2004 Aug;114(4):560-8. doi: 10.1172/JCI22206.
8
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.NKp46 和 DNAM-1 NK 细胞受体驱动对人巨细胞病毒感染的髓样树突状细胞的反应,克服病毒的免疫逃避策略。
Blood. 2011 Jan 20;117(3):848-56. doi: 10.1182/blood-2010-08-301374. Epub 2010 Oct 28.
9
Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.抑制MICA和MICB脱落可引发自然杀伤细胞介导的针对对细胞毒性T细胞耐药肿瘤的免疫反应。
Cancer Immunol Res. 2020 Jun;8(6):769-780. doi: 10.1158/2326-6066.CIR-19-0483. Epub 2020 Mar 24.
10
Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.卡波西肉瘤相关疱疹病毒K5对NKG2D和NKp80配体的下调可抵御自然杀伤细胞的细胞毒性。
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1656-61. doi: 10.1073/pnas.0707883105. Epub 2008 Jan 29.

引用本文的文献

1
HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine production.巨噬细胞的HIV-1感染以不同方式引发自然杀伤细胞的细胞毒性和促炎细胞因子的产生。
iScience. 2025 Jun 11;28(7):112879. doi: 10.1016/j.isci.2025.112879. eCollection 2025 Jul 18.
2
Impaired immune reconstitution in HIV infection: the role of CD4 T-cell-associated NKG2D ligands, CD4 T-cell subsets imbalance, and immune function deficiency.HIV感染中免疫重建受损:CD4 T细胞相关NKG2D配体、CD4 T细胞亚群失衡及免疫功能缺陷的作用
Front Immunol. 2025 Feb 21;16:1541574. doi: 10.3389/fimmu.2025.1541574. eCollection 2025.
3
Challenging the notion of endothelial infection by SARS-CoV-2: insights from the current scientific evidence.挑战新冠病毒感染内皮细胞的观念:基于当前科学证据的见解
Front Immunol. 2025 Feb 4;16:1443932. doi: 10.3389/fimmu.2025.1443932. eCollection 2025.
4
CXCR3-expressing myeloid cells recruited to the hypothalamus protect against diet-induced body mass gain and metabolic dysfunction.表达 CXCR3 的髓样细胞募集到下丘脑可预防饮食诱导的体重增加和代谢功能障碍。
Elife. 2024 Nov 13;13:RP95044. doi: 10.7554/eLife.95044.
5
Understanding emerging and re-emerging viruses to facilitate pandemic preparedness.了解新出现和再次出现的病毒以促进大流行防范。
Nat Microbiol. 2024 Sep;9(9):2208-2211. doi: 10.1038/s41564-024-01789-5.
6
S309-CAR-NK cells bind the Omicron variants and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.S309嵌合抗原受体自然杀伤细胞(S309-CAR-NK细胞)可结合奥密克戎变异株,并降低人源化血管紧张素转换酶2(ACE2)-NOD/SCID/IL2rgamma基因敲除(NSG)小鼠体内的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒载量。
J Virol. 2024 Jun 13;98(6):e0003824. doi: 10.1128/jvi.00038-24. Epub 2024 May 20.

本文引用的文献

1
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.严重急性呼吸综合征冠状病毒 ORF6 及其变异多态性对宿主反应和病毒发病机制的影响。
Cell Host Microbe. 2023 Oct 11;31(10):1668-1684.e12. doi: 10.1016/j.chom.2023.08.003. Epub 2023 Sep 21.
2
SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.SARS-CoV-2 ORF6 蛋白在感染呼吸道上皮细胞 Calu-3 时不会拮抗干扰素信号。
mBio. 2023 Aug 31;14(4):e0119423. doi: 10.1128/mbio.01194-23. Epub 2023 Jun 28.
3
Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19.具有促炎TEMRA表型的低亲和力循环严重急性呼吸综合征冠状病毒2反应性CD8+T细胞与冠状病毒病的急性后遗症相关。
Front Microbiol. 2023 Jun 2;14:1196721. doi: 10.3389/fmicb.2023.1196721. eCollection 2023.
4
Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion.核衣壳特异性 T 细胞应答与 SARS-CoV-2 在血清转换前在上呼吸道的控制有关。
Nat Commun. 2023 May 24;14(1):2952. doi: 10.1038/s41467-023-38020-8.
5
Coronaviral ORF6 protein mediates inter-organelle contacts and modulates host cell lipid flux for virus production.冠状病毒 ORF6 蛋白介导细胞器间的接触,并调节宿主细胞脂质流以促进病毒产生。
EMBO J. 2023 Jul 3;42(13):e112542. doi: 10.15252/embj.2022112542. Epub 2023 May 23.
6
Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants.奥密克戎亚变体增强了对 MHC-I 表达的抑制。
Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2221652120. doi: 10.1073/pnas.2221652120. Epub 2023 Apr 10.
7
SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants.患有癌症、艾滋病毒或实体器官移植的免疫功能低下个体中的SARS-CoV-2特异性T细胞反应。
Pathogens. 2023 Feb 3;12(2):244. doi: 10.3390/pathogens12020244.
8
Characterization of the HHV-6B U20 Immunoevasin.HHV-6B U20 免疫逃逸蛋白的特性分析。
J Virol. 2023 Feb 28;97(2):e0189022. doi: 10.1128/jvi.01890-22. Epub 2023 Jan 23.
9
SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression.SARS-CoV-2 的辅助蛋白 ORF7a 和 ORF3a 使用不同的机制下调 MHC-I 表面表达。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2208525120. doi: 10.1073/pnas.2208525120. Epub 2022 Dec 27.
10
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D.SARS-CoV-2 通过 Nsp1 介导的下调 NKG2D 的配体来逃避直接 NK 细胞杀伤。
Cell Rep. 2022 Dec 27;41(13):111892. doi: 10.1016/j.celrep.2022.111892. Epub 2022 Dec 12.